Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Sep 19, 2018
    Bigelow Named CHC Executive Director
  • Sep 18, 2018
    NAD Refers Ad Claims for Sun Care Products to FTC, FDA for Further Review
  • Sep 17, 2018
    N.J. Revokes License of Third Physician Over Subsys Prescribing
  • Sep 14, 2018
    Pricing in DTC Ads Dropped from Appropriations Bill
  • Sep 14, 2018
    Arizona Takes Purdue To Court Over Violation of 2007 Consent Order
  • Sep 10, 2018
    Colorado Files Suit Against Purdue Pharma Over Opioid Marketing
  • Sep 7, 2018
    Senate Bill Introduced Directing FDA to Prioritize Review of Opioid Marketing
  • Sep 7, 2018
    Maryland Files Suit Against Insys Over Deceptive Trade Practices in Speaker Program
  • Sep 7, 2018
    Senate Bill Takes Aim at DTC Advertising Deduction
  • Sep 6, 2018
    Goop Settles with California Task Force Over False and Misleading Statements
  • More

Good Clinical Practice

  • Dec 1, 2018
    OHRP Issues Draft Guidance on Public Health Surveillance Deemed Not Research
  • Nov 30, 2018
    Voluntary Code Established for Handling Health Care Data
  • Nov 29, 2018
    Investigator Sent Warning Letter for Ignoring Clinical Hold
  • Nov 26, 2018
    CDRH Plans To Improve Device Trial Patient Engagement
  • Nov 15, 2018
    CTTI Releases Recommendations To Better Prepare Investigators and Sites for Conducting Quality Trials
  • Nov 14, 2018
    FDA Qualifies First Trial Safety Biomarker
  • Nov 13, 2018
    FDA Issues Draft Guidance on Use of MFS as Endpoint for Prostate Cancer Trials
  • Nov 13, 2018
    FDA Proposes Allowing Waiver or Alteration of Informed Consent for Minimal Risk Research
  • Nov 12, 2018
    EMA Updates Guidance on Clinical Report Publication
  • Nov 8, 2018
    FDA Revises Expanded Access Web Pages, Adds Right-to-Try Page
  • More

U.S. Food Labeling

  • Dec 9,2014
    GMO Labeling Advocates in Oregon Sue Over Ballots Disqualified From Recount
  • Dec 8,2014
    FSIS Sets 2018 Compliance Date for Future Labeling Changes
  • Dec 4,2014
    U.S. Trade Rep. Appeals WTO Panel Decision Against COOL Rules
  • Dec 4,2014
    Ore. Begins Recount on GMO Labeling Measure
  • Nov 28,2014
    New Rule Sets Calorie Disclosure Requirements for Vending Machines
  • Nov 26,2014
    Final Menu Labeling Rule Gives Food Chains One Year To Provide Nutrition Information
  • Nov 25,2014
    Final Tally in Oregon Election Shows That GMO Ballot Measure Is Headed for Recount
  • Nov 24,2014
    Oregon’s GMO Labeling Measure Poised for Recount, 1,000 Votes Separate Sides in Debate
  • Nov 22,2014
    WLF Brief: Proof Should Be Required for All Class-actions Over Food Labeling Claims
  • Nov 18,2014
    Vermont Blasts Legal Theories Behind GMO Suit as ‘Extreme,’ Pushes for Case To Be Dismissed
  • More

FDA Regulation & Enforcement

  • Jan 6, 2022
    Omicron Surge Forces FDA To Cut Back on Inspections
  • Jan 6, 2022
    Ready or Not, Bioengineered Food Labeling Is Now in Effect
  • Dec 31, 2021
    Oregon Sets Temporary Rules for Sales Rep Licensing
  • Dec 29, 2021
    Court Bars N.J. Organization, Two Individuals from Marketing Nano Silver Products as COVID Treatments
  • Dec 24, 2021
    District Court Allows Qui Tam Suit Over Marketing Claims and Speaker Programs To Continue
  • Dec 23, 2021
    HHS OIG: Providing Free Eye Drops To Treat Side Effect of a Drug’s Use Will Not Trigger Sanctions
  • Dec 22, 2021
    FDA Gives Go-ahead to Peanut Health Claim, Signals Intent To Include Gum Acacia as Dietary Fiber
  • Dec 17, 2021
    FDA Plans To Release Final Rule on DTC Ads in September
  • Dec 16, 2021
    Iowa Man Pleads Guilty to Selling Prescription Vitamin B12 Injectable Online Without a Prescription
  • Dec 14, 2021
    House Committee Report Critiques Pharma Business, Pricing Practices
  • More

Medical Devices

  • Aug 12, 2017
    Studies To Support PMAs Lacking Age, Sex and Race/Ethnicity Reporting and Analysis
  • Aug 10, 2017
    FDA Finalizes Guidance on Qualifying Device Development Tools; Program May Speed Products to Market
  • Aug 2, 2017
    CDRH Action Plan Outlines ‘Pragmatic’ Approach to Regulating Digital Health Technology Devices
  • Aug 1, 2017
    FDA Launches Program for Precertifying Software Companies with Records of Quality Design, Validation
  • Jul 31, 2017
    FDA’s First Patient Engagement Advisory Committee Meeting To Focus on Trials
  • Jul 26, 2017
    CDRH Announces Voluntary Pilot Program for Assessing Quality of Device Manufacturing
  • Jul 20, 2017
    CDRH Updates Standard Recognition Request Procedure To Incorporate Cures Act Mandates
  • Jul 11, 2017
    FDA Finalizes List of Class II Devices Exempted from 510(k) Requirements Under Cures Act Procedure
  • Jul 5, 2017
    Appeals Court: Manufacturing Defect, Misrepresentation Claims Regarding PMA Device Are Not Preempted
  • Jun 28, 2017
    Device Maker Urges Supreme Court To Overturn Exclusion of 510(k) Clearance Evidence in Tort Suit
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.